BookMahfoozur Rahman, Waleed H. Almalki, Majed Alrobaian, Sarwar Beg, Khalid S. Alharbi, editors.
Summary: The nanotheranostics sector provides a very promising strategy for monitoring drug biodistribution and pathology longitudinal processes by integrating the imaging and drug delivery functions in one single nanoformulation, providing vital insights into the identification of tumour and predicting the efficacy of nanomedicine. For its unique properties, which include their small size and biocompatibility and ability to permeate the cellular membrane with carrying drugs, nanomaterials have been used for various biomedical applications. This book covers the progress made in hormone-related cancer and their management by nonmedicinal therapy for targeting the hormone regulated cancer with their clinical progress and clinical hurdles.
Contents:
Chapter 1. Conventional Treatment Approaches in Hormonal Cancer Treatment and Challenges
Chapter 2. Concept of Nanomedicine in Endocrine Hormone Cancer Treatment
Chapter 3. Progress of Cancer Nanomedicine, Clinical Hurdles and Opportunities
Chapter 4. Emergence of Nanohybrids in Hormonal Cancer Targeted Therapy
Chapter 5. Conventional to Nanoscale-Based Carrier System in Management of Ovarian Cancer
Chapter 6. Pancreatic Cancer Nanoparticles Targeted Therapy via Epidermal Growth Factor Receptor
Chapter 7. Nanocarriers Based Targeted Therapies for Pancreatic Cancer and Challenges Ahead
Chapter 8. Pancreatic Cancer Treatment by Using of Theranostics Nanoparticles
Chapter 9. Nanomedicine Based Combinational Therapy for Breast Cancer
Chapter 10. Nano-Liposomal System for Breast Cancer Therapy
Chapter 11. Conventional to Nanotherapeutic Strategies against Triple-Negative Breast Cancer
Chapter 12. Effect of Thymoquinone and Its Delivery Through Using of Nanomedicine in Benign Prostatic Hyperplasia
Chapter 13. Concept of Nanotechnology in Management of Neuroendocrine Tumours
Chapter 14. Neurocognitive Underpinning of Neurological Disorders: The Role of Default Mode Network
Chapter 15. Neuroendocrine Carcinoma of The Endometrium: Conventional Treatment Approach to Nanomedicine
Chapter 16. Effective Luteinizing Hormone Drug Delivery by Gold Nanoparticles in Hormonal Cancer Treatment
Chapter 17. Regulatory Landscapes in Approval of Cancer Vaccines.